276
Participants
Start Date
August 2, 2024
Primary Completion Date
February 29, 2032
Study Completion Date
February 29, 2032
AAV2-hAQP1
Administration of a prespecified concentration of AAV2-hAQP1 via Stensen's duct to each parotid gland
Erie County Medical Center, Buffalo
Alleghany General Hospital, Pittsburgh
Atrium Health, Charlotte
Miami Cancer Institute at Baptist Health South Florida, Miami
University of Iowa, Iowa City
University of Missouri, Columbia
Banner MD Anderson Cancer Center, Gilbert
Shirley and Jim Fielding Northeast Cancer Centre - Health Sciences North, Greater Sudbury
Lead Sponsor
MeiraGTx, LLC
INDUSTRY